Quote:
For instance, in a report released from the Ministry of Health in Israel, the effectiveness of 2 doses of the BNT162b2 (Pfizer-BioNTech) vaccine against preventing COVID-19 infection was reported to be 39% [6],
substantially lower than the trial efficacy of 96% [7]. It is also emerging that immunity derived from the Pfzer-BioNTech vaccine may not be as strong as immunity acquired through recovery from the COVID-19 virus [8]. A substantial decline in immunity from mRNA vaccines 6-months post immunization has also been reported [9]. Even though vaccination offers protection to individuals against severe hospitalization and death, the CDC reported an increase
from 0.01 to 9% and 0 to 15.1% (between January to May 2021) in the rates of hospitalizations and deaths, respectively, among the fully vaccinated [10].
Now, 39% vs 96% is a very interesting discrepancy. Might it indicate that the trial data was "doctored"? And an increase in the rates of hospitalization among the fully vaccinated is very hard to ignore. But it will be ignored.